000			02032 a2200613 4500
005			20250516151446.0
264		0	_c20131023
008			201310s 0 0 eng d
022			_a2041-4889
024	7		_a10.1038/cddis.2013.157 _2doi
040			_aNLM _beng _cNLM
100	1		_aMurphy, Á C
245	0	0	_aActivation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach. _h[electronic resource]
260			_bCell death & disease _cMay 2013
300			_ae629 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlgorithms
650	0	4	_aAntineoplastic Agents, Alkylating _xtoxicity
650	0	4	_aApoptosis Regulatory Proteins
650	0	4	_aApoptotic Protease-Activating Factor 1 _xmetabolism
650	0	4	_aBrain Neoplasms _xmetabolism
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aCaspase 9 _xmetabolism
650	0	4	_aCaspases _xmetabolism
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDacarbazine _xanalogs & derivatives
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aGlioblastoma _xmetabolism
650	0	4	_aHumans
650	0	4	_aIntracellular Signaling Peptides and Proteins _xmetabolism
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMitochondrial Proteins _xmetabolism
650	0	4	_aTemozolomide
650	0	4	_aX-Linked Inhibitor of Apoptosis Protein _xmetabolism
700	1		_aWeyhenmeyer, B
700	1		_aSchmid, J
700	1		_aKilbride, S M
700	1		_aRehm, M
700	1		_aHuber, H J
700	1		_aSenft, C
700	1		_aWeissenberger, J
700	1		_aSeifert, V
700	1		_aDunst, M
700	1		_aMittelbronn, M
700	1		_aKögel, D
700	1		_aPrehn, J H M
700	1		_aMurphy, B M
773	0		_tCell death & disease _gvol. 4 _gp. e629
856	4	0	_uhttps://doi.org/10.1038/cddis.2013.157 _zAvailable from publisher's website
999			_c22758166 _d22758166